Report / Trial registry metadata
Bergonie Institut Profiling : Fighting Cancer by Matching Molecular Alterations and Drugs in Early Phase Trials
This study concerns Solid Tumor, Hematological Malignancy. Its registered status is recruiting. The planned measures below describe the study design, not demonstrated treatment effects.
What is being studied?
- Conditions
- Solid Tumor, Hematological Malignancy
- Study type
- Interventional
- Purpose
- Diagnostic
- Phase
- NA
How is the study designed?
- Enrollment
- 10000 (estimated)
- Group design
- Single group
- Allocation
- Not applicable
- Masking
- None
- Minimum age
- 18 Years
- Eligibility sex
- All
Which interventions are listed?
- Procedure: Newly obtained biopsy and Blood samples collection
What will the study measure?
- Proportion of patients presenting at least one genomic alteration Assessment window: 1 month
What can this record establish?
These are registered plans and status information. Enrollment marked estimated is a target, not a verified count of participants already studied. The measures listed do not establish that an intervention succeeded. Eligibility criteria and recruitment status must be checked against the full study record before considering participation.
- Kind
- Trial registry metadata
- Identifier
- NCT02534649
- Status
- RECRUITING